Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shopify
SHOP
|
+$417M |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$344M |
| 3 |
Baidu
BIDU
|
+$254M |
| 4 |
American Electric Power
AEP
|
+$214M |
| 5 |
Intuitive Surgical
ISRG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.19B |
| 2 |
Microsoft
MSFT
|
+$1.44B |
| 3 |
Intel
INTC
|
+$925M |
| 4 |
NVIDIA
NVDA
|
+$589M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.94% |
| 2 | Healthcare | 6.98% |
| 3 | Consumer Discretionary | 5.82% |
| 4 | Financials | 5.54% |
| 5 | Industrials | 4.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
PUT
Universal Display
OLED
$4.19B
| $3.27M | ﹤0.01% |
+13,800
| New | +$3.19M |
|
3002
Essential Properties Realty Trust
EPRT
$6.62B
| $3.27M | ﹤0.01% |
+143,060
| New | +$3.2M |
|
|
NVRO
3003
DELISTED
NEVRO CORP.
NVRO
| $3.26M | ﹤0.01% |
23,363
-49,228
| -68% | -$8.03M |
|
3004
Koppers
KOP
$969M
| $3.25M | ﹤0.01% |
93,600
+38,563
| +70% | +$1.35M |
|
|
TFFP
3005
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
| $3.25M | ﹤0.01% |
9,587
+5,498
| +134% | +$2.24M |
|
3006
United Microelectronic
UMC
$46.9B
| $3.25M | ﹤0.01% |
356,532
+325,928
| +1,065% | +$3.01M |
|
|
STPC.U
3007
DELISTED
Star Peak Corp II Units, each consisting of one share of Class A common stock and one-fourth of one
STPC.U
| $3.25M | ﹤0.01% |
+310,142
| New | +$3.59M |
|
3008
Beam Global
BEEM
$25.3M
| $3.24M | ﹤0.01% |
74,625
-25,035
| -25% | -$1.32M |
|
3009
BiomX
PHGE
$1.85M
| $3.23M | ﹤0.01% |
2,391
-30
| -1% | -$40.6K |
|
3010
Plug Power
PLUG
$3.04B
| $3.23M | ﹤0.01% |
90,244
-1,019,770
| -92% | -$52.6M |
|
|
AMPE
3011
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $3.23M | ﹤0.01% |
6,368
+5,458
| +600% | +$2.81M |
|
3012
Centrus Energy
LEU
$3.82B
| $3.23M | ﹤0.01% |
135,992
+96,557
| +245% | +$2.31M |
|
3013
Service Corp International
SCI
$11.6B
| $3.23M | ﹤0.01% |
63,179
-294,153
| -82% | -$14.7M |
|
3014
CALL
Inovio Pharmaceuticals
INO
$69M
| $3.22M | ﹤0.01% |
28,942
-225
| -0.8% | -$29.6K |
|
|
SRNE
3015
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $3.22M | ﹤0.01% |
389,462
+373,960
| +2,412% | +$3.95M |
|
|
RMGB
3016
DELISTED
RMG Acquisition Corp. II Class A Ordinary Shares
RMGB
| $3.22M | ﹤0.01% |
+321,162
| New | +$3.47M |
|
|
SEEL
3017
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $3.22M | ﹤0.01% |
+168
| New | +$1.96M |
|
|
CSLT
3018
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $3.21M | ﹤0.01% |
2,124,597
+505,603
| +31% | +$877K |
|
3019
Dick's Sporting Goods
DKS
$18.7B
| $3.21M | ﹤0.01% |
42,100
-82,726
| -66% | -$5.95M |
|
3020
Brink's
BCO
$4.62B
| $3.21M | ﹤0.01% |
40,457
-37,207
| -48% | -$2.81M |
|
3021
CALL
Dow Inc
DOW
$21.2B
| $3.2M | ﹤0.01% |
50,000
| – | – |
|
|
CAI
3022
DELISTED
CAI International, Inc.
CAI
| $3.19M | ﹤0.01% |
70,179
-63,622
| -48% | -$2.51M |
|
3023
CALL
Caesars Entertainment
CZR
$6.14B
| $3.19M | ﹤0.01% |
36,500
+33,600
| +1,159% | +$2.82M |
|
3024
Ocular Therapeutix
OCUL
$2.02B
| $3.19M | ﹤0.01% |
+194,295
| New | +$3.74M |
|
3025
PUT
Chegg
CHGG
$102M
| $3.19M | ﹤0.01% |
37,200
-212,800
| -85% | -$20.3M |
|
Similar funds
Millennium Management's Q1 2021 Portfolio in Review
As of Q1 2021, Millennium Management held 6,933 positions worth $140B, up 0.91% from $138B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Millennium Management's Q1 2021 filing shows 1,778 new, 1,837 increased, 2,117 reduced and 1,099 closed positions. Its largest new stake was KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant: 9,400,000 shares worth $94.1M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $3.19B.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, down from 11% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Millennium Management's largest Q1 2021 buy was KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant: 9,400,000 shares worth $94.1M.
- Millennium Management added most to Shopify in Q1 2021, an estimated $417M increase.
- Millennium Management's biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.19B.
- Millennium Management fully exited iShares Russell 2000 ETF in Q1 2021, selling an estimated $573M.
- Millennium Management's ten largest holdings make up 21% of its $140B portfolio in Q1 2021.
- Millennium Management opened 1,778 new positions and closed 1,099 in Q1 2021.
- Millennium Management's portfolio value rose 0.91% quarter-over-quarter to $140B.
Based on Millennium Management's 13F filing for Q1 2021, filed 17 May 2021.